These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18067031)

  • 1. Developing the science base for reducing tobacco harm.
    Hatsukami DK; Joseph AM; Lesage M; Jensen J; Murphy SE; Pentel PR; Kotlyar M; Borgida E; Le C; Hecht SS
    Nicotine Tob Res; 2007 Nov; 9 Suppl 4(0 4):S537-53. PubMed ID: 18067031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing harm caused by tobacco. Research findings from the University of Minnesota.
    Hecht S; Hatsukami D
    Minn Med; 2005 Apr; 88(4):40-3. PubMed ID: 15942995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to reduce harm from continued tobacco use.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005231. PubMed ID: 17636791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco smoking, harm reduction, and biomarkers.
    Shields PG
    J Natl Cancer Inst; 2002 Oct; 94(19):1435-44. PubMed ID: 12359853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing tobacco harm: research challenges and issues.
    Hatsukami DK; Slade J; Benowitz NL; Giovino GA; Gritz ER; Leischow S; Warner KE
    Nicotine Tob Res; 2002; 4 Suppl 2():S89-101. PubMed ID: 12573171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is reduction of tobacco consumption associated with reduced risk of cardiovascular and pulmonary mortality and morbidity?].
    Underner M; Peiffer G; Perriot J; Harika-Germaneau G; Jaafari N
    Rev Pneumol Clin; 2018 Jun; 74(3):188-195. PubMed ID: 29748063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco harm reduction: a call to address the ethical dilemmas.
    Fox BJ; Cohen JE
    Nicotine Tob Res; 2002; 4 Suppl 2():S81-7. PubMed ID: 12573170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
    Parascandola M
    Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deniers and Admitters: Examining Smoker Identities in a Changing Tobacco Landscape.
    Kingsbury JH; Parks MJ; Amato MS; Boyle RG
    Nicotine Tob Res; 2016 Nov; 18(11):2130-2137. PubMed ID: 27085084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco harm reduction: conceptual structure and nomenclature for analysis and research.
    Shiffman S; Gitchell JG; Warner KE; Slade J; Henningfield JE; Pinney JM
    Nicotine Tob Res; 2002; 4 Suppl 2():S113-29. PubMed ID: 12573173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community tobacco control leaders' perceptions of harm reduction.
    Joseph AM; Hennrikus D; Thoele MJ; Krueger R; Hatsukami D
    Tob Control; 2004 Jun; 13(2):108-13. PubMed ID: 15175521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco harm reduction strategies: the case for physical activity.
    deRuiter W; Faulkner G
    Nicotine Tob Res; 2006 Apr; 8(2):157-68. PubMed ID: 16766410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program.
    Smith MR; Clark B; Lüdicke F; Schaller JP; Vanscheeuwijck P; Hoeng J; Peitsch MC
    Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S17-S26. PubMed ID: 27450400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory strategies to reduce tobacco addiction in youth.
    Henningfield JE; Moolchan ET; Zeller M
    Tob Control; 2003 Jun; 12 Suppl 1(Suppl 1):i14-24. PubMed ID: 12773782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health service user and staff perspectives on tobacco addiction and smoking cessation: A meta-synthesis of published qualitative studies.
    Malone V; Harrison R; Daker-White G
    J Psychiatr Ment Health Nurs; 2018 May; 25(4):270-282. PubMed ID: 29498459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: 5
    Higgins ST
    Prev Med; 2018 Dec; 117():1-4. PubMed ID: 30340697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reflections on 30+ years of smoking cessation research: from the individual to the world.
    Lando HA
    Drug Alcohol Rev; 2006 Jan; 25(1):5-14. PubMed ID: 16492572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco use: prevention, cessation, and control.
    Ranney L; Melvin C; Lux L; McClain E; Morgan L; Lohr KN
    Evid Rep Technol Assess (Full Rep); 2006 Jun; (140):1-120. PubMed ID: 17764211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotheses and fundamental study design characteristics for evaluating potential reduced-risk tobacco products. Part I: Heuristic.
    Murrelle L; Coggins CR; Gennings C; Carchman RA; Carter WH; Davies BD; Krauss MR; Lee PN; Schleef RR; Zedler BK; Heidbreder C
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):1-10. PubMed ID: 20018224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.
    Henningfield JE; Benowitz NL; Slade J; Houston TP; Davis RM; Deitchman SD
    Tob Control; 1998; 7(3):281-93. PubMed ID: 9825424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.